227 CO Patents Case Neg - Patents Neg DDI 2008...

Info iconThis preview shows pages 1–2. Sign up to view the full content.

View Full Document Right Arrow Icon

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: Patents Neg DDI 2008 <CO> Elliot Stoller Solvency Frontline ...................................................................................................................................................... 1 Innovation Frontline ........................................................................................................................................................................................ 6 Competitive Frontline .............................................................................................................................................. 6 Easy Patents Hurt Innovation ................................................................................................................................... 7 Generic Drug Turn Extension ................................................................................................................................. 18 Court of Appeals CP ................................................................................................................................................. 19 Solvency Extensions ................................................................................................................................................. 20 Legitimacy Net Benefit ............................................................................................................................................. 21 Extensions ................................................................................................................................................................. 23 Congress CP ............................................................................................................................................................... 26 Solvency Frontline 1. Turn. Easy access to patents stifles innovation prefer our evidence, its from a Nobel Laureate in Economics. Dugie Standeford , for Intellectual Property Watch, Intellectual Property Regime Stifles Science and Innovation, Nobel Laureates Say 9-7-08 MANCHESTER, UK - The basic framework of the intellectual property (IP) regime aims to close down access to knowledge rather than allowing its dissemination , Professor Joseph Stiglitz said at a 5 July lecture on Who Owns Science? Stiglitz, a 2001 Nobel Laureate in Economics, and Professor John Sulston, a 2002 Nobel Laureate in Physiology/Medicine, launched Manchester Universitys new Institute for Science, Ethics and Innovation. Both were highly critical of todays patent system, saying it stifles science and innovation. IP is often compared to physical property rights but knowledge is fundamentally different, Stiglitz said. It is a public good with two attributes - non-rivalrous competition and non-excludability - meaning it is difficult to prevent others from enjoying its benefits. That runs counter to IP regimes, which are worse than exclusion because they create monopoly power over knowledge that is often abused, he said. Patent monopolies are believed to drive innovation but they actually impede the pace ofknowledge that is often abused, he said....
View Full Document

Page1 / 27

227 CO Patents Case Neg - Patents Neg DDI 2008...

This preview shows document pages 1 - 2. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online